Udho Thadani to Coronary Disease
This is a "connection" page, showing publications Udho Thadani has written about Coronary Disease.
Connection Strength
1.219
-
Treatment with statins in high-risk patients: relevance of time to titration of dose and adverse outcomes. Am J Cardiovasc Drugs. 2009; 9(3):211-2; author reply 212.
Score: 0.307
-
Side effects of using nitrates to treat angina. Expert Opin Drug Saf. 2006 Sep; 5(5):667-74.
Score: 0.261
-
Lack of arrhythmogenicity with ST-segment elevation during high-dose of dobutamine atropine stress in patients with documented or suspected coronary artery disease. Am J Cardiol. 1997 Aug 01; 80(3):341-3.
Score: 0.139
-
Oral nitrates: more than symptomatic therapy in coronary artery disease? Cardiovasc Drugs Ther. 1997 May; 11 Suppl 1:213-8.
Score: 0.137
-
Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance. Curr Probl Cardiol. 1988 Nov; 13(11):723-84.
Score: 0.076
-
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005 Jun 27; 165(12):1401-9.
Score: 0.060
-
Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris. Z Kardiol. 1985; 74 Suppl 4:21-4.
Score: 0.058
-
Management of patients with chronic stable angina at low risk for serious cardiac events. Am J Cardiol. 1997 Jun 26; 79(12B):24-30.
Score: 0.034
-
Hemodynamics at rest and during supine and sitting bicycle exercise in patients with coronary artery disease. Am J Cardiol. 1977 May 26; 39(6):776-83.
Score: 0.034
-
Beta-adrenergic blockers and intermittent claudication. Time for reappraisal. Arch Intern Med. 1991 Sep; 151(9):1705-7.
Score: 0.023
-
Mechanisms of myocardial ischemia induced by epinephrine: comparison with exercise-induced ischemia. Psychosom Med. 1988 Jul-Aug; 50(4):381-93.
Score: 0.019
-
Effects of 1-epinephrine on hemodynamics and cardiac function in coronary disease: dose-response studies. Clin Pharmacol Ther. 1988 Mar; 43(3):308-16.
Score: 0.018
-
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2008 Feb; 31(2):353-60.
Score: 0.018
-
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2006 Sep; 48(3):374-84.
Score: 0.016
-
Are the clinical and hemodynamic events during exercise stress testing in invasive studies in patients with angina pectoris reproducible? Circulation. 1980 Apr; 61(4):744-50.
Score: 0.010
-
Clinical, hemodynamic and metabolic responses during pacing in the supine and sitting postures in patients with angina pectoris. Am J Cardiol. 1979 Aug; 44(2):249-56.
Score: 0.010